Join
Live feed
·
INSIDERFilingvia Quantisnow
Keros Therapeutics Inc. logo

Large owner Pontifax Management 4 G.P. (2015) Ltd. sold $84,975,125 worth of shares (4,787,331 units at $17.75) (SEC Form 4)

ByQuantisnow·Wall Street's wire, on your screen.
KROS· Keros Therapeutics Inc.
Health Care
Original source

This insight was delivered by - Wall Street's wire, on your screen. Quantisnow is a real-time market data and news platform for retail investors, aggregating SEC filings, FDA approvals, analyst ratings, insider trading, and press releases into a single customizable feed. Track KROS (Keros Therapeutics Inc.) and more on Quantisnow.